|
FAM103A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.180220E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.027600E-02 |
| Normal-vs-Stage2 |
2.348300E-02 |
| Normal-vs-Stage3 |
1.363940E-03 |
| Normal-vs-Stage4 |
3.239300E-04 |
| Stage1-vs-Stage2 |
2.765400E-01 |
| Stage1-vs-Stage3 |
1.678980E-01 |
| Stage1-vs-Stage4 |
3.280100E-02 |
| Stage2-vs-Stage3 |
8.653200E-01 |
| Stage2-vs-Stage4 |
4.703400E-01 |
| Stage3-vs-Stage4 |
2.268000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.478900E-03 |
| Normal-vs-AfricanAmerican |
7.480200E-02 |
| Normal-vs-Asian |
1.110980E-01 |
| Caucasian-vs-AfricanAmerican |
6.739200E-01 |
| Caucasian-vs-Asian |
6.912200E-01 |
| AfricanAmerican-vs-Asian |
5.369400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.199200E-04 |
| Normal-vs-Female |
4.323600E-03 |
| Male-vs-Female |
2.711600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.405900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.637900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.366400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.821800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.223000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.307700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.878800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.763800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.426200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.445600E-01 |
| Classical-VS-Follicular |
3.788600E-01 |
| Classical-VS-Other |
5.305000E-01 |
| Classical-VS-Normal |
1.194330E-02 |
| Tall-VS-Follicular |
9.153800E-01 |
| Tall-VS-Other |
3.578200E-01 |
| Tall-VS-Normal |
1.942400E-02 |
| Follicular-VS-Other |
4.622400E-01 |
| Follicular-VS-Normal |
1.299710E-02 |
| Other-VS-Normal |
8.716600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.956200E-03 |
| Normal-vs-N1 |
1.585740E-04 |
| N0-vs-N1 |
7.924100E-02 |
|
|
